➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ALITRETINOIN

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Alitretinoin

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002188	A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Ligand Pharmaceuticals	Phase 2	1969-12-31	The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002188	A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Anderson Clinical Research	Phase 2	1969-12-31	The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002439	A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Ligand Pharmaceuticals	N/A	1969-12-31	The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
NCT00002439	A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Anderson Clinical Research	N/A	1969-12-31	The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Alitretinoin

Condition Name

Chart
Table

Condition Name for Alitretinoin
Intervention	Trials
Hand Dermatoses	3
Eczema	2
HIV Infections	2
Sarcoma, Kaposi	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Chart
Table

Condition MeSH for Alitretinoin
Intervention	Trials
Eczema	6
Dermatitis	4
Sarcoma	3
Skin Diseases	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Alitretinoin

Trials by Country

Map
Table

Trials by Country for Alitretinoin
Location	Trials
United States	32
Germany	11
Canada	6
Netherlands	3
Denmark	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Map
Table

Trials by US State for Alitretinoin
Location	Trials
District of Columbia	1
New York	1
Georgia	1
Idaho	1
Illinois	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Alitretinoin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Alitretinoin
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	8
Phase 2	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Chart
Table

Clinical Trial Status for Alitretinoin
Clinical Trial Phase	Trials
Completed	11
Recruiting	3
Terminated	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Alitretinoin

Sponsor Name

Chart
Table

Sponsor Name for Alitretinoin
Sponsor	Trials
Basilea Pharmaceutica	6
Anderson Clinical Research	2
Ligand Pharmaceuticals	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Chart
Table

Sponsor Type for Alitretinoin
Sponsor	Trials
Other	15
Industry	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

McKesson

Baxter

Johnson and Johnson

Mallinckrodt

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.